Simplex Trading »

Candel Therapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2024-09-30 $158k 23k 6.92
2024-06-30 $31k 5.0k 6.20

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Nvidia Corporation Call Call Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Apple Call Call Option
Tesla Call Call Option
Tesla Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Meta Platforms Call Call Option
Spdr Gold Tr Call Call Option

View all positions for Simplex Trading

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Sands Capital Ventures
Nuveen Asset Management
Susquehanna International
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Jane Street
HB Wealth Management
Charles Schwab Investment Management

View all funds holding Candel Therapeutics